Health / Health News

    Protein domain common to plants and animals plays role in COVID-19 infection

    Oak Ridge National Laboratory scientists exploring bioenergy plant genetics have made a surprising discovery: a protein domain that could lead to new COVID-19 treatments.



    ORNL scientists mutated amino acids in a receptor protein, shown in green, which diminished interaction with the SARS-CoV-2 virus spike protein, shown in red. Mutating the receptor protein hampered the virus’s ability to infect host cells. Credit: ORNL, U.S. Dept. of Energy


    Researchers found the same plasminogen-apple-nematode, or PAN, domain studied by ORNL in plants like poplar and willow is also present in the human NRP1 receptor protein.

    NRP1 is less studied than the ACE-2 receptor targeted by current COVID-19 treatments, but this research shows its promise as a future therapeutic target.

    By mutating amino acids called cysteine residues in the PAN domain of NRP1, researchers disrupted the ability of the SARS-CoV-2 virus to use its spike protein to invade cells, as described in iScience. ORNL scientists have also linked PAN to the growth of cancerous tumors.

    “This project provides more evidence that PAN is involved in host cell invasion,” said ORNL’s Wellington Muchero. “By pinpointing these amino acids, researchers could reduce viral interaction with host cells.” (Oak Ridge National Laboratory)

    APRIL 25, 2023



    YOU MAY ALSO LIKE

    Genes linked to severity and duration of childhood diarrhoea identified.
    Parents who frequently exercise harsh discipline with young children are putting them at significantly greater risk of developing lasting mental health problems, new evidence shows.
    A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
    Individuals who are obese may be more susceptible to severe COVID-19 because of a poorer inflammatory immune response, say Cambridge scientists.
    Study confirms white blood cell subtype as HIV reservoir, suggests new target for cure efforts.
    "Gatekeeper" mutations make enzymes called kinases more active.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact